Lu B, Abdel-Wahab O. Promoting spliceosome assembly for therapeutic intent. Trends Pharmacol Sci. 2021. https://doi.org/10.1016/j.tips.2021.09.006.
Plaschka C, Lin P, Charenton C, Nagai K. Prespliceosome structure provides insights into spliceosome assembly and regulation. Nature. 2018;559(7714):419–22. https://doi.org/10.1038/s41586-018-0323-8.
CAS Article PubMed PubMed Central Google Scholar
Zhou Z, Gong Q, Wang Y, Li M, Wang L, Ding H, Li P. The biological function and clinical significance of SF3B1 mutations in cancer. Biomarker Res. 2020;8:38. https://doi.org/10.1186/s40364-020-00220-5.
Borišek J, Casalino L, Saltalamacchia A, Mays S, Malcovati L, Magistrato A. Atomic-level mechanism of pre-mRNA splicing in health and disease. Acc Chem Res. 2021;54(1):144–54. https://doi.org/10.1021/acs.accounts.0c00578.
CAS Article PubMed Google Scholar
Wang E, Aifantis I. RNA splicing and cancer. Trends Cancer. 2020;6(8):631–44. https://doi.org/10.1016/j.trecan.2020.04.011.
CAS Article PubMed Google Scholar
Nguyen J, Drabarek W, Yavuzyigitoglu S, Medico Salsench E, Verdijk R, Naus N, de Klein A, Kiliç E, Brosens E. Spliceosome mutations in uveal melanoma. Int J Mol Sci. 2020;21(24). https://doi.org/10.3390/ijms21249546.
Coltri P, Dos Santos M, da Silva G. Splicing and cancer: challenges and opportunities. Wiley Interdisciplinary Reviews RNA. 2019;10(3):e1527. https://doi.org/10.1002/wrna.1527.
Perez-Santángelo S, Mancini E, Francey L, Schlaen R, Chernomoretz A, Hogenesch J, Yanovsky M. Role for LSM genes in the regulation of circadian rhythms. Proc Natl Acad Sci U S A. 2014;111(42):15166–71. https://doi.org/10.1073/pnas.1409791111.
CAS Article PubMed PubMed Central Google Scholar
Fuentes-Fayos A, Vázquez-Borrego M, Jiménez-Vacas J, Bejarano L, Pedraza-Arévalo S, L-López F, Blanco-Acevedo C, Sánchez-Sánchez R, Reyes O, Ventura S, Solivera J, Breunig J, Blasco M, Gahete M, Castaño J, Luque R. Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3. Brain. 2020;143(11):3273–93. https://doi.org/10.1093/brain/awaa273.
Article PubMed PubMed Central Google Scholar
Wang S, Wang Z, Li J, Qin J, Song J, Li Y, Zhao L, Zhang X, Guo H, Shao C, Kong B, Liu Z. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2. Cell Death Dis. 2021;12(4):294. https://doi.org/10.1038/s41419-021-03581-3.
CAS Article PubMed PubMed Central Google Scholar
Pradella D, Deflorian G, Pezzotta A, Di Matteo A, Belloni E, Campolungo D, Paradisi A, Bugatti M, Vermi W, Campioni M, Chiapparino A, Scietti L, Forneris F, Giampietro C, Volf N, Rehman M, Zacchigna S, Paronetto M, Pistocchi A, et al. A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis. Nat Commun. 2021;12(1):4872. https://doi.org/10.1038/s41467-021-24998-6.
CAS Article PubMed PubMed Central Google Scholar
Yang H, Beutler B, Zhang D. Emerging roles of spliceosome in cancer and immunity. Protein Cell. 2021. https://doi.org/10.1007/s13238-021-00856-5.
Bowling E, Wang J, Gong F, Wu W, Neill N, Kim I, Tyagi S, Orellana M, Kurley S, Dominguez-Vidaña R, Chung H, Hsu T, Dubrulle J, Saltzman A, Li H, Meena,J, Canlas G, Chamakuri S, Singh S, Simon L, Olson C, Dobrolecki L, Lewis M, Zhang B, Golding I, Rosen J, Young D, Malovannaya A, Stossi F, Miles G, Ellis M, Yu L, Buonamici S, Lin C, Karlin K, Zhang X, Westbrook T. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 2021; 184 (2): 384-403.e21. https://doi.org/10.1016/j.cell.2020.12.031.
Sciarrillo R, Wojtuszkiewicz A, Assaraf Y, Jansen G, Kaspers G, Giovannetti E, Cloos J. The role of alternative splicing in cancer: from oncogenesis to drug resistance. Drug Resist Updat. 2020;53:100728. https://doi.org/10.1016/j.drup.2020.100728.
López-Cánovas J, Del Rio-Moreno M, García-Fernandez H, Jiménez-Vacas J, Moreno-Montilla M, Sánchez-Frias M, Amado V, L-López F, Fondevila M, Ciria R, Gómez-Luque I, Briceño J, Nogueiras R, de la Mata M, Castaño J, Rodriguez-Perálvarez M, Luque R, Gahete M. Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma. Cancer Lett. 2021;496:72–83. https://doi.org/10.1016/j.canlet.2020.10.010.
CAS Article PubMed Google Scholar
Fox R, Lytle N, Jaquish D, Park F, Ito T, Bajaj J, Koechlein C, Zimdahl B, Yano M, Kopp J, Kritzik M, Sicklick J, Sander M, Grandgenett P, Hollingsworth M, Shibata S, Pizzo D, Valasek M, Sasik R, et al. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Nature. 2016;534(7607):407–11. https://doi.org/10.1038/nature17988.
CAS Article PubMed PubMed Central Google Scholar
Chen W, To M, Westcott P, Delrosario R, Kim I, Philips M, Tran Q, Bollam S, Goodarzi H, Bayani N, Mirzoeva O, Balmain A. Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells. Nat Commun. 2021;12(1):4288. https://doi.org/10.1038/s41467-021-24498-7.
CAS Article PubMed PubMed Central Google Scholar
Lu M, Zhan H, Liu B, Li D, Li W, et al. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer. EPMA J. 2021;12:589–604. https://doi.org/10.1007/s13167-021-00259-w.
Article PubMed PubMed Central Google Scholar
Cheng T, Zhan X. Pattern recognition for predictive, preventive, and personalized medicine in cancer. EPMA J. 2017;8:51–60. https://doi.org/10.1007/s13167-017-0083-9.
CAS Article PubMed PubMed Central Google Scholar
Shi Y, Yuan J, Rraklli V, Maxymovitz E, Cipullo M, Liu M, Li S, Westerlund I, Bedoya-Reina O, Bullova P, Rorbach J, Juhlin C, Stenman A, Larsson C, Kogner P, O'Sullivan M, Schlisio S, Holmberg J. Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors. Nucleic Acids Res. 2021;49(5):2509–21. https://doi.org/10.1093/nar/gkab054.
CAS Article PubMed PubMed Central Google Scholar
Lv Z, Wang Z, Luo L, Chen Y, Han G, Wang R, Xiao H, Li X, Hou C, Feng J, Shen B, Wang Y, Peng H, Guo R, Li Y, Chen G. Spliceosome protein Eftud2 promotes colitis-associated tumorigenesis by modulating inflammatory response of macrophage. Mucosal Immunol. 2019;12(5):1164–73. https://doi.org/10.1038/s41385-019-0184-y.
CAS Article PubMed Google Scholar
Cieśla M, Ngoc P, Cordero E, Martinez Á, Morsing M, Muthukumar S, Beneventi G, Madej M, Munita R, Jönsson T, Lövgren K, Ebbesson A, Nodin B, Hedenfalk I, Jirström K, Vallon-Christersson J, Honeth G, Staaf J, Incarnato D, et al. Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer. Mol Cell. 2021;81(7):1453–1468.e12. https://doi.org/10.1016/j.molcel.2021.01.034.
CAS Article PubMed Google Scholar
Du J, Zhu G, Cai J, Wang B, Luo Y, Chen C, Cai C, Zhang S, Zhou J, Fan J, Zhu W, Dai Z. Splicing factors: insights into their regulatory network in alternative splicing in cancer. Cancer Lett. 2021;501:83–104. https://doi.org/10.1016/j.canlet.2020.11.043.
CAS Article PubMed Google Scholar
Hautin M, Mornet C, Chauveau A, Bernard D, Corcos L, Lippert E. Splicing anomalies in myeloproliferative neoplasms: paving the way for new therapeutic venues. Cancers. 2020;12(8). https://doi.org/10.3390/cancers12082216.
Inoue D, Polaski J, Taylor J, Castel P, Chen S, Kobayashi S, Hogg S, Hayashi Y, Pineda J, El Marabti E, Erickson C, Knorr K, Fukumoto M, Yamazaki H, Tanaka A, Fukui C, Lu S, Durham B, Liu B, et al. Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition. Nat Genet. 2021;53(5):707–18. https://doi.org/10.1038/s41588-021-00828-9.
CAS Article PubMed PubMed Central Google Scholar
Aird D, Teng T, Huang C, Pazolli E, Banka D, Cheung-Ong K, Eifert C, Furman C, Wu Z, Seiler M, Buonamici S, Fekkes P, Karr C, Palacino J, Park E, Smith P, Yu L, Mizui Y, Warmuth M, et al. Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators. Nat Commun. 2019;10(1):137. https://doi.org/10.1038/s41467-018-08150-5.
CAS Article PubMed PubMed Central Google Scholar
Dvinge H, Guenthoer J, Porter P, Bradley R. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing. Genome Res. 2019;29(10):1591–604. https://doi.org/10.1101/gr.246678.118.
CAS Article PubMed PubMed Central Google Scholar
Tam B, Chiu K, Chung H, Bossard C, Nguyen J, Creger E, Eastman B, Mak C, Ibanez M, Ghias A, Cahiwat J, Do L, Cho S, Nguyen J, Deshmukh V, Stewart J, Chen C, Barroga C, Dellamary L, et al. The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models. Cancer Lett. 2020;473:186–97. https://doi.org/10.1016/j.canlet.2019.09.009.
CAS Article PubMed Google Scholar
Ishak C, Loo Yau H, De Carvalho D. Spliceosome-targeted therapies induce dsRNA responses. Immunity. 2021;54(1):11–3. https://doi.org/10.1016/j.immuni.2020.12.012.
CAS Article PubMed Google Scholar
Gatica D, Hu G, Liu X, Zhang N, Williamson P, Klionsky D. The Pat1-Lsm complex stabilizes ATG mRNA during nitrogen starvation-induced autophagy. Mol Cell. 2019;73(2):314–324.e4. https://doi.org/10.1016/j.molcel.2018.11.002.
CAS Article PubMed Google Scholar
Ta H, Wang W, Phan N, An Ton N, Anuraga G, et al. Potential therapeutic and prognostic values of LSM family genes in breast cancer. Cancers. 2021;13. https://doi.org/10.3390/cancers13194902.
Liu N, Chen A, Feng N, Liu X, Zhang L. SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer. Med Oncol. 2021;38(5):57. https://doi.org/10.1007/s12032-021-01502-0.
CAS Article PubMed Google Scholar
Zhan Y, Li L, Zeng T, Zhou N, Guan X, Li Y. SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma. Aging. 2020;13(1):537–54. https://doi.org/10.18632/aging.202164.
Article PubMed PubMed Central Google Scholar
Liu N, Wu Z, Chen A, Wang Y, Cai D, Zheng J, Liu Y, Zhang L. SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26. Cell Death Dis. 2019;10(9):667. https://doi.org/10.1038/s41419-019-1929-y.
CAS Article PubMed PubMed Central Google Scholar
Yoshimi A, Lin K, Wiseman D, Rahman M, Pastore A, Wang B, Lee S, Micol J, Zhang X, de Botton S, Penard-Lacronique V, Stein E, Cho H, Miles R, Inoue D, Albrecht T, Somervaille T, Batta K, Amaral F, et al. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. Nature. 2019;574(7777):273–7. https://doi.org/10.1038/s41586-019-1618-0.
留言 (0)